ABL Bio’s License Agreement with SANOFI

Martina Bellini
Tagged:

Wilson Sonsini Goodrich & Rosati advised ABL on the deal.ABL Bio, Inc., a clinical-stage biotech developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases, announced an…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now